HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Olubanke Dzahini Selected Research
Olubanke Dzahini Research Topics
Disease
7
Psychotic Disorders (Schizoaffective Disorder)
01/2024 - 01/2020
6
Neutropenia
01/2023 - 01/2019
5
Treatment-Resistant Schizophrenia
10/2021 - 01/2020
2
Schizophrenia (Dementia Praecox)
01/2024 - 01/2022
2
Infections
01/2023 - 01/2022
2
Sialorrhea
01/2022 - 01/2020
2
Drug-Related Side Effects and Adverse Reactions
10/2021 - 01/2017
1
Tardive Dyskinesia
01/2024
1
COVID-19
01/2023
1
Agranulocytosis (Granulocytopenia)
01/2022
1
Mental Disorders (Mental Disorder)
01/2021
1
Confusion (Bewilderment)
01/2020
1
Headache (Headaches)
01/2020
1
Tachycardia (Tachyarrhythmias)
01/2020
1
Fatigue
01/2020
1
Dizziness (Lightheadedness)
01/2020
1
Weight Gain
01/2020
1
Constipation
01/2020
1
Venous Thromboembolism
07/2018
1
Atrial Fibrillation
07/2018
1
Movement Disorders (Movement Disorder)
01/2015
Drug/Important Bio-Agent (IBA)
14
Clozapine (Clozaril)
FDA Link
Generic
12/2023 - 01/2019
6
Antipsychotic Agents (Antipsychotics)
IBA
01/2024 - 01/2015
2
Antidepressive Agents (Antidepressants)
IBA
01/2022 - 01/2017
1
valbenazine
IBA
01/2024
1
Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)
IBA
01/2024
1
deutetrabenazine
IBA
01/2024
1
Tetrabenazine (Nitoman)
FDA Link
01/2024
1
Vortioxetine
IBA
01/2022
1
Metoclopramide (Reglan)
FDA Link
Generic
01/2022
1
Paliperidone Palmitate
FDA Link
01/2022
1
Penfluridol (Semap)
IBA
01/2022
1
Vitamin K
FDA Link
07/2018
Therapy/Procedure
3
Therapeutics
01/2022 - 01/2015